Natriuretic peptides and genesis of asthma: An emerging paradigm?

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 3, 2004, Pages 520-526

  Mohapatra, Shyam S ^a,b   Lockey, Richard F ^a   Vesely, David L ^a   Gower Jr , William R ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

ANP; asthma; Atrial natriuretic peptide; bronchodilation; cGMP; Cyclic guanosine monophosphate; ERK; Extracellular receptor kinase; inflammation; kaliuretic peptide; Kaliuretic peptide; KP; MAPK; nuclear factor B

Indexed keywords

AMINO ACID DERIVATIVE; BRAIN NATRIURETIC PEPTIDE; ENDOTHELIN; FIBROBLAST GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; NATRIURETIC FACTOR; NATRIURETIC PEPTIDE TYPE C; PROTEIN DERIVATIVE;

ALLERGIC ASTHMA; BREATHING MUSCLE; CELL MIGRATION; HORMONAL REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOREACTIVITY; MOLECULAR INTERACTION; MOLECULAR MECHANICS; MUSCLE HYPERTROPHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 4444341170     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.05.028     Document Type: Article

References (73)

1. Akbari O., Stock P., Meyer E., Kronenberg M., Sidobre S., Nakayama T., et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 9:2003;582-588
2. Saetta M., Fabbri L.M., Danieli D., Picotti G., Allegra L. Pathology of bronchial asthma and animal models of asthma. Eur Respir J Suppl. 6:1989;477s-482s
3. Vesely D.L. Atrial natriuretic peptides in pathophysiological diseases. Cardiovasc Res. 51:2001;647-658
4. Beltowski J. [N-terminal atrial natriuretic peptides]. Postepy Hig Med Dosw. 54:2000;895-914
5. Vesely D.L., Chiou S., Douglass M.A., McCormick M.T., Rodriguez-Paz G., Schocken D.D. Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion. J Endocrinol. 146:1995;373-380
6. Ji D., Zeng Q., Shen H., Fan Y.X., Chen W., Song Y.L. [Role of kaliuretic peptide and molar ratio of kaliuretic peptide/atrial natriuretic peptide in atrial fibrillation]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 15:2003;459-461
7. Hamad A.M., Johnson S.R., Knox A.J. Antiproliferative effects of NO and ANP in cultured human airway smooth muscle. Am J Physiol. 277:1999;L910-L918
8. Overton R.M., Vesely D.L. Processing of kaliuretic peptide in human plasma and serum. Peptides. 17:1996;1041-1046
9. Vesely D.L., Douglass M.A., Dietz J.R., Gower W.R. Jr., McCormick M.T., Rodriguez-Paz G., et al. Three peptides from the atrial natriuretic factor prohormone amino terminus lower blood pressure and produce diuresis, natriuresis, and/or kaliuresis in humans. Circulation. 90:1994;1129-1140
10. Vesely D.L., Giordano A.T., Douglass M.A., McCormick M.T., Rodriguez-Paz G., Schocken D.D. Atrial natriuretic peptides and cyclic guanosine monophosphate metabolism. Am J Med Sci. 310:1995;143-149
11. Chiou S., Vesely D.L. Kaliuretic peptide: the most potent inhibitor of Na(+)-K+ ATPase of the atrial natriuretic peptides. Endocrinology. 136:1995;2033-2039
12. Vesely D.L., Overton R.M., Blankenship M., McCormick M.T., Schocken D.D. Atrial natriuretic peptide increases urodilatin in the circulation. Am J Nephrol. 18:1998;204-213
13. Vesely D.L., Chiou S., Douglass M.A., McCormick M.T., Rodriguez-Paz G., Schocken D.D. Atrial natriuretic peptides negatively and positively modulate circulating endothelin in humans. Metabolism. 45:1996;315-319
14. Levin E.R., Gardner D.G., Samson W.K. Natriuretic peptides. N Engl J Med. 339:1998;321-328
15. Forssmann W., Meyer M., Forssmann K. The renal urodilatin system: clinical implications. Cardiovasc Res. 51:2001;450-462
16. Ohsaki Y., Yang H.K., Le P.T., Jensen R.T., Johnson B.E. Human small cell lung cancer cell lines express functional atrial natriuretic peptide receptors. Cancer Res. 53:1993;3165-3171
17. Matsukawa N., Grzesik W.J., Takahashi N., Pandey K.N., Pang S., Yamauchi M., et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A. 96:1999;7403-7408
18. Abbey S.E., Potter L.R. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B. Endocrinology. 144:2003;240-246
19. Silberbach M., Roberts C.T. Jr. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal. 13:2001;221-231
20. Bueno O.F., De Windt L.J., Lim H.W., Tymitz K.M., Witt S.A., Kimball T.R., et al. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ Res. 88:2001;88-96
21. Vesely D.L., San Miguel G.I., Hassan I., Gower W.R. Jr., Schocken D.D. Atrial natriuretic hormone, vessel dilator, long-acting natriuretic hormone, and kaliuretic hormone decrease the circulating concentrations of total and tree T4 and free T3 with reciprocal increase in TSH. J Clin Endocrinol Metab. 86:2001;5438-5442
22. Sakamoto M., Nakao K., Morii N., Sugawara A., Yamada T., Itoh H., et al. The lung as a possible target organ for atrial natriuretic polypeptide secreted from the heart. Biochem Biophys Res Commun. 135:1986;515-520
23. Chrisman T.D., Schulz S., Potter L.R., Garbers D.L. Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides. J Biol Chem. 268:1993;3698-3703
24. Tallerico-Melnyk T., Yip C.C., Watt V.M. Widespread co-localization of mRNAs encoding the guanylate cyclase-coupled natriuretic peptide receptors in rat tissues. Biochem Biophys Res Commun. 189:1992;610-616
25. Deschepper C.F., Picard S. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors. J Neurochem. 62:1994;1974-1982
26. Komatsu Y., Nakao K., Itoh H., Suga S., Ogawa Y., Imura H. Vascular natriuretic peptide. Lancet. 340:1992;622
27. Panchenko M.P., Joyce-Brady M., Starikova M.G., Oakes S.M., Adachi R., Brody J.S., et al. Atrial natriuretic peptide modulates alveolar type 2 cell adenylyl and guanylyl cyclases and inhibits surfactant secretion. Biochim Biophys Acta. 1403:1998;115-125
28. Perreault T., Gutkowska J. Role of atrial natriuretic factor in lung physiology and pathology. Am J Respir Crit Care Med. 151:1995;226-242
29. Gutkowska J., Nemer M. Structure, expression, and function of atrial natriuretic factor in extraatrial tissues. Endocr Rev. 10:1989;519-536
30. Aiton J.F.C., Rugg E.L. Inhibition of atrial natriuretic peptide degradation in rat heart, lung and kidney tissue. J Physiol (Lond). 392:1987;97
31. Mantyh C.R., Kruger L., Brecha N.C., Mantyh P.W. Localization of specific binding sites for atrial natriuretic factor in peripheral tissues of the guinea pig, rat, and human. Hypertension. 8:1986;712-721
32. Boyd R.L., Hugo P. Towards an integrated view of thymopoiesis. Immunol Today. 12:1991;71-79
33. Vollmar A.M., Schulz R. Atrial natriuretic peptide in lymphoid organs of various species. Comp Biochem Physiol A. 96:1990;459-463
34. Gerbes A.L., Vollmar A.M., Thibault G., Arendt R.M., Cantin M., Paumgartner G. Different behaviour of the N-terminal and C-terminal fragment of proatrial natriuretic factor in plasma of healthy subjects as well as of patients with cirrhosis. Scand J Clin Lab Invest. 50:1990;195-198
35. Vollmar A.M., Schmidt K.N., Schulz R. Natriuretic peptide receptors on rat thymocytes: inhibition of proliferation by atrial natriuretic peptide. Endocrinology. 137:1996;1706-1713
36. Izumi T., Saito Y., Kishimoto I., Harada M., Kuwahara K., Hamanaka I., et al. Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury. J Clin Invest. 108:2001;203-213
37. Kiemer A.K., Vollmar A.M. Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J Biol Chem. 273:1998;13444-13451
38. Kiemer A.K., Hartung T., Vollmar A.M. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J Immunol. 165:2000;175-181
39. Dai Y.S., Cserjesi P., Markham B.E., Molkentin J.D. The transcription factors GATA4 and dHAND physically interact to synergistically activate cardiac gene expression through a p300-dependent mechanism. J Biol Chem. 277:2002;24390-24398
40. Szukiewicz D., Maslinska D., Szukiewicz A., Zaczek R., Szewczyk G., Stelmachow J. The dose-dependent release of histamine from placental mast cells after administration of atrial natriuretic peptide. Inflamm Res. 50:(suppl 2):2001;S59-S60
41. Chai O.H., Lee Y.H., Han E.H., Kim H.T., Lee M.S., Song C.H. Atrial natriuretic peptide induces rat peritoneal mast cell activation by cGMP-independent and calcium uptake-dependent mechanism. Exp Mol Med. 32:2000;179-186
42. Morita R., Ukyo N., Furuya M., Uchiyama T., Hori T. Atrial natriuretic Peptide polarizes human dendritic cells toward a th2-promoting phenotype through its receptor guanylyl cyclase-coupled receptor a. J Immunol. 170:2003;5869-5875
43. Moss R.B., Golightly M.G. In vitro enhancement of natural cytotoxicity by atrial natriuretic peptide fragment 4-28. Peptides. 12:1991;851-854
44. Leitman D.C., Andresen J.W., Catalano R.M., Waldman S.A., Tuan J.J., Murad F. Atrial natriuretic peptide binding, cross-linking, and stimulation of cyclic GMP accumulation and particulate guanylate cyclase activity in cultured cells. J Biol Chem. 263:1988;3720-3728
45. Kiemer A.K., Bildner N., Weber N.C., Vollmar A.M. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology. 144:2003;802-812
46. Pedram A., Razandi M., Kehrl J., Levin E.R. Natriuretic peptides inhibit G protein activation. Mediation through cross-talk between cyclic GMP-dependent protein kinase and regulators of G protein-signaling proteins. J Biol Chem. 275:2000;7365-7372
47. Chanez P., Mann C., Bousquet J., Chabrier P.E., Godard P., Braquet P., et al. Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma. J Allergy Clin Immunol. 86:1990;321-324
48. Hulks G., Jardine A.G., Connell J.M., Thomson N.C. Effect of atrial natriuretic factor on bronchomotor tone in the normal human airway. Clin Sci (Colch). 79:1990;51-55
49. Angus R.M., McCallum M.J., Hulks G., Thomson N.C. Bronchodilator, cardiovascular, and cyclic guanylyl monophosphate response to high-dose infused atrial natriuretic peptide in asthma. Am Rev Respir Dis. 147:1993;1122-1125
50. Hulks G., Thomson N.C. High dose inhaled atrial natriuretic peptide is a bronchodilator in asthmatic subjects. Eur Respir J. 7:1994;1593-1597
51. Angus R.M., McCallum M.J., Thomson N.C. Effect of inhaled atrial natriuretic peptide on methacholine induced bronchoconstriction in asthma. Clin Exp Allergy. 24:1994;784-788
52. Fluge T., Fabel H., Wagner T.O., Schneider B., Forssmann W.G. Urodilatin (ularitide, INN): a potent bronchodilator in asthmatic subjects. Eur J Clin Invest. 25:1995;728-736
53. Ohbayashi H., Suito H., Takagi K. Compared effects of natriuretic peptides on ovalbumin-induced asthmatic model. Eur J Pharmacol. 346:1998;55-64
54. Pedram A., Razandi M., Levin E.R. Natriuretic peptides suppress vascular endothelial cell growth factor signaling to angiogenesis. Endocrinology. 142:2001;1578-1586
55. Thrane E.V., Schwarze P.E., Thoresen G.H., Lag M., Refsnes M. Persistent versus transient map kinase (ERK) activation in the proliferation of lung epithelial type 2 cells. Exp Lung Res. 27:2001;387-400
56. Ishikawa Y., Kitamura M. Dual potential of extracellular signal-regulated kinase for the control of cell survival. Biochem Biophys Res Commun. 264:1999;696-701
57. Abell T.J., Richards A.M., Ikram H., Espiner E.A., Yandle T. Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factor. Biochem Biophys Res Commun. 160:1989;1392-1396
58. Appel R.G. Growth inhibitory activity of atrial natriuretic factor in rat glomerular mesangial cells. FEBS Lett. 238:1988;135-138
59. Kumar M., Behera A.K., Lockey R.F., Vesely D.L., Mohapatra S.S. Atrial natriuretic peptide gene transfer by means of intranasal administration attenuates airway reactivity in a mouse model of allergic sensitization. J Allergy Clin Immunol. 110:2002;879-882
60. Hofmann F., Ammendola A., Schlossmann J. Rising behind NO: cGMP-dependent protein kinases. J Cell Sci. 113:(suppl):2000;1671-1676
61. Holgate S.T., Lackie P., Wilson S., Roche W., Davies D. Bronchial epithelium as a key regulator of airway allergen sensitization and remodeling in asthma. Am J Respir Crit Care Med. 162:(suppl):2000;S113-S117
62. Ueda Y., Hirai S., Osada S., Suzuki A., Mizuno K., Ohno S. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem. 271:1996;23512-23519
63. Xu K.P., Dartt D.A., Yu F.S. EGF-induced ERK phosphorylation independent of PKC isozymes in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 43:2002;3673-3679
64. Hood J., Granger H.J. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells. J Biol Chem. 273:1998;23504-23508
65. Busse W.W., Lemanske R.F. Jr. Asthma. N Engl J Med. 344:2001;350-362
66. Kiemer A.K., Vollmar A.M. Effects of different natriuretic peptides on nitric oxide synthesis in macrophages. Endocrinology. 138:1997;4282-4290
67. Kiemer A.K., Vollmar A.M. Elevation of intracellular calcium levels contributes to the inhibition of nitric oxide production by atrial natriuretic peptide. Immunol Cell Biol. 79:2001;11-17
68. Kiemer A.K., Vollmar A.M., Bilzer M., Gerwig T., Gerbes A.L. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol. 33:2000;236-246
69. Kiemer A.K., Weber N.C., Vollmar A.M. Induction of IkappaB: atrial natriuretic peptide as a regulator of the NF-kappaB pathway. Biochem Biophys Res Commun. 295:2002;1068-1076
70. Tsukagoshi H., Shimizu Y., Kawata T., Hisada T., Iwamae S., Ishizuka T., et al. Atrial natriuretic peptide inhibits tumor necrosis factor-alpha production by interferon-gamma-activated macrophages via suppression of p38 mitogen-activated protein kinase and nuclear factor-kappa B activation. Regul Pept. 99:2001;21-29
71. Kiemer A.K., Weber N.C., Furst R., Bildner N., Kulhanek-Heinze S., Vollmar A.M. Inhibition of p38 MAPK activation via induction of MKP-1: atrial natriuretic peptide reduces TNF-alpha-induced actin polymerization and endothelial permeability. Circ Res. 90:2002;874-881
72. Hellermann G., Kong X., Gunnarsdottir J., San Juan H., Singam R., Behera S., et al. Mechanism of bronchoprotective effects of a novel natriuretic hormone peptide. J Allergy Clin Immunol. 113:2004;79-85
73. Toda M., Tulic M.K., Levitt R.C., Hamid Q. A calcium-activated chloride channel (HCLCA1) is strongly related to IL-9 expression and mucus production in bronchial epithelium of patients with asthma. J Allergy Clin Immunol. 109:2002;246-250